Vimarsana
Biggest News Aggregation in the World

Page 28 - Clinical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Today - Breaking & Trending Today

The Conversation: AI has the potential to revolutionise healthcare – but we must first confront the risk of algorithmic bias - Vimarsana News

The Conversation: AI has the potential to revolutionise healthcare – but we must first confront the risk of algorithmic bias

AI algorithms may have inherent biases that could lead to discrimination.

EQS-News: Immunic Reports Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease, Providing Clinical Proof-of-Concept for New Therapeutic Approach to Gastrointestinal Disorders - Vimarsana News

EQS-News: Immunic Reports Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease, Providing Clinical Proof-of-Concept for New Therapeutic Approach to Gastrointestinal Disorders

Issuer: Immunic, Inc. / Key word(s): Study results Immunic Reports Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease, Providing Clinical Proof-of-Concept for New Therapeutic Approach to Gastrointestinal Disorders 04.05.2023 / 12:30 CET/CEST The issuer is solely responsib...

New law will reimburse cancer patients for trials - Vimarsana News

New law will reimburse cancer patients for trials

Governor Brian Kemp signed SB223 into law Tuesday.

IPL 2023: Clinical Lucknow Super Giants hammer Punjab Kings by 56 runs - Vimarsana News

IPL 2023: Clinical Lucknow Super Giants hammer Punjab Kings by 56 runs

Superb batting show followed by collective bowling performance helped Lucknow Super Giants (LSG) hammer Punjab...

GSK breathes hope into respiratory biz in country - Vimarsana News

GSK breathes hope into respiratory biz in country

Global biopharmaceutical company GlaxoSmithKline is scheduled to submit market approvals in China for about 15 new drugs and indications over the next three years and more than 20 clinical research projects will be conducted in the country, said a senior executive of the company.